Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system.
Peripheral inflammation is known to trigger neuroinflammation and neurodegenerative disease. However, the key components during the propagation of inflammation from the periphery to the central nervous system (CNS) remain unclear. Lipopolysaccharide (LPS) was administered to Sprague-Dawley rats to induce peripheral inflammation. An intravenous injection and an intranigral injection of clodronate liposomes were given to deplete monocytes and microglia, respectively. Recombinant CD200 fusion protein (CD200Fc) or an anti-CD200R1 antibody was injected into the substantia nigra to manipulate the involvement of CD200 and CD200R1. Immunohistochemistry and immunofluorescence staining were used to measure microglial activation and dopaminergic neuronal loss. The expression of brain pro-inflammatory cytokines (i.e., tumor necrosis factor alpha, IL-1β) and CD200-CD200R1 signaling were measured by quantitative RT-PCR. Our data showed that the peripheral LPS injection activated the microglia and induced an increase in the levels of pro-inflammatory cytokines (i.e., tumor necrosis factor alpha, IL-1β). The depletion of either monocytes or microglia suppressed these inflammatory effects that were induced by peripheral LPS administration. The peripheral LPS injection increased the expression of CD200 and CD200R1 in the substantia nigra. Dopaminergic neuronal loss induced by the peripheral LPS injection was accelerated by the blockade of CD200-CD200R1 signaling with an anti-CD200R1 antibody and attenuated by intensifying the signaling with CD200Fc. These results highlight the importance of monocytes, microglia, and CD200-CD200R1 signaling in the transmission of inflammation from the periphery to the CNS.
Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, China.
Xin
X
Xie
Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, China.
Xiaoguang
0000-0001-9828-0626
X
Luo
Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, China.
Na
N
Liu
Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, China.
Xiaohong
X
Li
Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, China.
Fan
F
Lou
Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, China.
Yumin
Y
Zheng
Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, China.
Yan
Y
Ren
D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis*; D002490:Central Nervous System / Q000378:metabolism / Q000473:pathology; D059290:Dopaminergic Neurons / Q000378:metabolism / Q000473:pathology; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D018836:Inflammation Mediators / Q000378:metabolism*; D008297:Male; D017628:Microglia / Q000378:metabolism* / Q000473:pathology; D009000:Monocytes / Q000378:metabolism* / Q000473:pathology; D064446:Orexin Receptors / Q000096:biosynthesis*; D017933:Peripheral Nervous System / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000502:physiology
D015703:Antigens, CD; C501103:Cd200r1 protein, mouse; D018836:Inflammation Mediators; D064446:Orexin Receptors; C042739:antigens, CD200
CD200; CD200R1; Parkinson's disease; microglia; monocyte; peripheral inflammation